ACM
CTKB icon

Aquatic Capital Management’s Cytek Biosciences CTKB Stock Holding History

Aquatic Capital Management’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Buy
+76,762
New +$328K 0.01% 896
2026
Q1 		– Sell
-306
Closed -$1.54K – 1460
2025
Q4 		$1.54K Sell
306
-83,844
-100% -$389K ﹤0.01% 1355
2025
Q3 		$292K Buy
84,150
+63,900
+316% +$240K 0.01% 1009
2025
Q2 		$68.8K Buy
20,250
+19,984
+7,513% +$66.6K ﹤0.01% 1122
2025
Q1 		$1.07K Sell
266
-3,519
-93% -$18.2K ﹤0.01% 1210
2024
Q4 		$24.6K Buy
+3,785
New +$22.5K ﹤0.01% 1226

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Aquatic Capital Management's CTKB Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Cytek Biosciences (CTKB) in Q2 2026: 76,762 shares worth $340K. The stake represents 0.01% of the portfolio and ranks #896 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in CTKB as recently as Q4 2025.

Aquatic Capital Management first reported a position in CTKB in Q4 2024 and has held it in 6 quarters since. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Aquatic Capital Management held 76,762 shares of Cytek Biosciences worth $340K as of Q2 2026.
  • Cytek Biosciences was a new Aquatic Capital Management position in Q2 2026.
  • Cytek Biosciences made up 0.01% of Aquatic Capital Management's portfolio in Q2 2026, its #896 holding.
  • Aquatic Capital Management first reported a position in Cytek Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.